1. Overexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy
    Yang Jia et al, 2015 CrossRef
  2. Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks
    Christina Schoenherr et al, 2017 CrossRef
  3. Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer
    JUN HU et al, 2014 CrossRef
  4. Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy
    Yang Jia et al, 2017, Thorac Cancer CrossRef
  5. Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
    Seema C Parte et al, 2017, Stem Cells Dev CrossRef
  6. IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling
    Jiaqi Min et al, 2018, FEBS Open Bio CrossRef
  7. Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma
    Yuli Hou et al, 2019, Medicine CrossRef
  8. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia
    Yan Liu et al, 2019, Cancer Gene Ther CrossRef
  9. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells
    Chai Phei Gan et al, 2019, Cell Oncol. CrossRef
  10. G3BP1 and G3BP2 regulate translation of interferon-stimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7
    Umber Alam et al, 2019, Mol Cell Biochem CrossRef
  11. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway
    Xi Liu et al, 2019, Cell Death Dis CrossRef
  12. Identification of germ cell-specific VASA and IFITM3 proteins in human ovarian endometriosis
    Nicolas A. Fraunhoffer et al, 2015, J Ovarian Res CrossRef
  13. Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes
    Stosh Ozog et al, 2019 CrossRef
  14. Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma
    Hao Li et al, 2020 CrossRef
  15. An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
    Ming-Kai Chuang et al, 2015, Oncotarget CrossRef
  16. Role of Chikungunya nsP3 in Regulating G3BP1 Activity, Stress Granule Formation and Drug Efficacy
    Xue Lu et al, 2020, Archives of Medical Research CrossRef
  17. Malignancy and IFITM3: Friend or Foe?
    Ushani S. Rajapaksa et al, 2020, Front. Oncol. CrossRef
  18. Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer
    Veronica Ferrucci et al, 2021, iScience CrossRef
  19. Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors
    Yun Cai et al, 2021, Front. Immunol. CrossRef
  20. Integrative overview of IFITMs family based on Bioinformatics analysis
    Pengchao Liu et al, 2021, IRDR CrossRef
  21. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis
    Pei-Yi Chu et al, 2022, Cell Biosci CrossRef
  22. Identification of potential modulators of IFITM3 by in-silico modeling and virtual screening
    Vikas Tiwari et al, 2022, Sci Rep CrossRef
  23. IFITM protein regulation and functions: Far beyond the fight against viruses
    Nela Friedlová et al, 2022, Front. Immunol. CrossRef
  24. IFITM proteins: understanding their diverse roles in viral infection, cancer, and immunity
    Maria Gómez-Herranz et al, 2022, Journal of Biological Chemistry CrossRef
  25. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer
    Suman Mazumder et al, 2022, Cancers CrossRef
  26. Does IFITM3 link inflammation to tumorigenesis?
    Jaewoong Lee, 2022, BMB Rep CrossRef
  27. Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation
    Ruifeng Yang et al, 2023, Oncogene CrossRef
  28. IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases
    Séverine A. Degrelle et al, 2023, iScience CrossRef
  29. IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma
    Se Un Jeong et al, 2024, Investig Clin Urol CrossRef
  30. Personalized differential expression analysis in triple-negative breast cancer
    Hao Cai et al, 2024 CrossRef
  31. Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis
    Jihua Zhang et al, 2024 CrossRef
  32. Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer
    Peipei Wang et al, 2024, Med Oncol CrossRef
  33. A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer
    Aaron G. Baugh et al, 2024, Clin Exp Metastasis CrossRef